Boston MA B细胞淋巴瘤临床试验
10项针对 B细胞淋巴瘤的研究正在 Boston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- Tufts Medical Center, Boston
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
招募中3 期
- Dana Farber Cancer Institute Longwood Medical Center, Boston
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
招募中1/2 期
- Research Site, Boston
GLORY: Glofit-GemOx With Liso-Cel For Lymphoma
招募中2 期
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
招募中1 期
- Massachusetts General Hospital, Boston
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
招募中1/2 期
- Massachusetts General Hospital, Boston
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Dana Farber Cancer Institute, Boston
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
招募中1/2 期
- Harvard Medical School - Massachusetts General Hospital, Boston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Dana-Farber Cancer Institute, Boston
其他城市的 B细胞淋巴瘤试验
- New York City, NY17 项研究
- Houston, TX16 项研究
- Chicago, IL13 项研究
- Nashville, TN12 项研究
- Philadelphia, PA11 项研究
- Rochester, MN10 项研究
- Milwaukee, WI10 项研究
- Baldwin Park, CA9 项研究
- Cleveland, OH8 项研究
- Salt Lake City, UT8 项研究
- Seattle, WA8 项研究
- Pittsburgh, PA7 项研究
Boston的其他研究
- 乳腺癌110 项研究
- 癌症（所有类型）90 项研究
- 非小细胞肺癌87 项研究
- 肺癌63 项研究
- 结直肠癌62 项研究
- 卵巢癌62 项研究
- 转移性癌症61 项研究
- 前列腺癌56 项研究
- 子宫内膜癌51 项研究
- 抑郁症50 项研究
- 心力衰竭46 项研究
- 多发性骨髓瘤45 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。